ConductScience.org, home

Trial · NCT01435018

Adverse events345

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnaemiaBlood and lymphatic system disordersBleomycin Plus Vincristine (BV) Plus Co-formulated EFV/FTC/TDF5132
otherAnaemiaBlood and lymphatic system disordersEtoposide (ET) Plus Co-formulated EFV/FTC/TDF659
otherAnaemiaBlood and lymphatic system disordersPaclitaxel (PTX) Plus Co-formulated EFV/FTC/TDF3138
otherAbdominal painGastrointestinal disordersBleomycin Plus Vincristine (BV) Plus Co-formulated EFV/FTC/TDF5132
otherAbdominal painGastrointestinal disordersEtoposide (ET) Plus Co-formulated EFV/FTC/TDF559
otherAbdominal painGastrointestinal disordersPaclitaxel (PTX) Plus Co-formulated EFV/FTC/TDF9138
otherDiarrhoeaGastrointestinal disordersBleomycin Plus Vincristine (BV) Plus Co-formulated EFV/FTC/TDF9132
otherDiarrhoeaGastrointestinal disordersEtoposide (ET) Plus Co-formulated EFV/FTC/TDF859
otherDiarrhoeaGastrointestinal disordersPaclitaxel (PTX) Plus Co-formulated EFV/FTC/TDF17138
otherGastritisGastrointestinal disordersBleomycin Plus Vincristine (BV) Plus Co-formulated EFV/FTC/TDF3132
otherGastritisGastrointestinal disordersEtoposide (ET) Plus Co-formulated EFV/FTC/TDF359
otherGastritisGastrointestinal disordersPaclitaxel (PTX) Plus Co-formulated EFV/FTC/TDF1138
otherVomitingGastrointestinal disordersBleomycin Plus Vincristine (BV) Plus Co-formulated EFV/FTC/TDF13132
otherVomitingGastrointestinal disordersEtoposide (ET) Plus Co-formulated EFV/FTC/TDF959
otherVomitingGastrointestinal disordersPaclitaxel (PTX) Plus Co-formulated EFV/FTC/TDF13138
otherAstheniaGeneral disordersBleomycin Plus Vincristine (BV) Plus Co-formulated EFV/FTC/TDF7132
otherAstheniaGeneral disordersEtoposide (ET) Plus Co-formulated EFV/FTC/TDF259
otherAstheniaGeneral disordersPaclitaxel (PTX) Plus Co-formulated EFV/FTC/TDF4138
otherChest painGeneral disordersBleomycin Plus Vincristine (BV) Plus Co-formulated EFV/FTC/TDF13132
otherChest painGeneral disordersEtoposide (ET) Plus Co-formulated EFV/FTC/TDF559

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01435018/events